Latest stories

  • in

    Dr Reddys Labs concludes acquisition of Mayne Pharma’s US generic prescription product portfolio

    Dr Reddys Labs concludes acquisition of Mayne Pharma's US generic prescription product portfolio

    Hyderabad: Pharma major, Dr Reddys Labs, has recently announced that the company has completed the acquisition of Mayne Pharma’s U.S. generic prescription product portfolio. The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health. For the financial period ended June […] More

  • in

    Piramal Pharma Digwal facility successfully concludes USFDA inspection

    Mumbai: Piramal Pharma Limited has recently announced that the US Food and Drug Administration (USFDA) has successfully completed the Good Manufacturing Practices (GMP) inspection with Zero Form – 483 observations at the company’s Digwal facility. An FDA Form 483 is issued to firm management at the conclusion of an inspection when an investigator(s) has observed […] More